Acellular Pertussis Completed Phase 3 Trials for Meningococcal polysaccharide vaccine group C (DB13890)

IndicationStatusPhase
DBCOND0031302 (Acellular Pertussis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00463437Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same VaccinesPrevention